You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COPD subjects

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD Trial in London (CHF6523)

Completed
  • COPD
  • London, United Kingdom
    Richmond Pharmacology
Jan 23, 2023

COPD, Smoking, Tobacco Use Trial in Praha (THS use, Cigarette, Smoking Abstinence)

Recruiting
  • COPD
  • +2 more
  • THS use
  • +2 more
  • Praha, Czechia
    Clinitrial, s.r.o.
Dec 16, 2022

COPD Trial in Hannover (Olodaterol-Tiotropium)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Hannover, Niedersachsen, Germany
    Fraunhofer ITEM
Jan 9, 2023

COPD (COPD) Trial (Tesamorelin, Placebo)

Terminated
Has Results
  • Chronic Obstructive Pulmonary Disease (COPD)
  • (no location specified)
Mar 9, 2022

Asthma, COPD Trial in Orsay (1. Standard spirometry, 2. 3D dynamic lung MRI at UTE in prone and supine positions, 3.

Not yet recruiting
  • Asthma
  • COPD
  • 1. Standard spirometry
  • +3 more
  • Orsay, France
    CEA | Service Hospitalier Fréderic Joliot
Feb 2, 2023

COPD, Healthy Trial in Hannover (Exposure to clean air, Exposure to urban air)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Healthy
  • Exposure to clean air
  • Exposure to urban air
  • Hannover, Lower Saxony, Germany
    Fraunhofer ITEM
Sep 12, 2023

Microbiological Diversity in Exhaled Air in Chronic Obstructive

Not yet recruiting
  • Chronic Obstructive Pulmonary Disease
  • collection of human exhalation
  • (no location specified)
Jun 24, 2022

COPD Trial in Jacksonville (Mesenchymal Stem Cells)

Active, not recruiting
  • Chronic Obstructive Pulmonary Disease
  • Mesenchymal Stem Cells
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 8, 2022

COPD Trial (AER-01, Placebo)

Not yet recruiting
  • COPD
  • (no location specified)
May 8, 2023

Home-based Sensor System to Detect Health Decompensation in

Recruiting
  • COPD
  • +4 more
  • Data collection
  • Neptune, New Jersey
    Jersey Shore University Medical Center, Hackensack Meridian Heal
May 9, 2023

COPD Trial in Tradate (Standard pulmonary rehabilitation program, Balance training added on standard pulmonary rehabilitation)

Recruiting
  • COPD
  • Standard pulmonary rehabilitation program
  • Balance training added on standard pulmonary rehabilitation
  • Tradate, Varese, Italy
    Department of pulmonary rehabilitation
Jul 25, 2023

Asthma Trial in Manchester (KN-002)

Recruiting
  • Asthma COPD
  • Manchester, United Kingdom
    Medicines Evaluation Unit
Aug 30, 2022

COPD, Pulmonary Hypertension, COPD Trial in Edegem (Inhaled Nitric Oxide 30mcg/kg IBW/hr)

Terminated
  • COPD
  • +2 more
  • Inhaled Nitric Oxide 30mcg/kg IBW/hr
  • Edegem, Belgium
    Antwerp University Hospital
Aug 9, 2022

COPD Trial in China (Revefenacin 175 mcg in 3 ML Inhalation Solution, Placebo inhalation solution QD)

Recruiting
  • COPD
  • Revefenacin 175 mcg in 3 ML Inhalation Solution
  • Placebo inhalation solution QD
  • Beijing, Beijing, China
  • +2 more
Feb 22, 2022

Asthma, COPD, Atopic Dermatitis Trial in Beijing (Experimental drug 9MW1911, Placebo)

Active, not recruiting
  • Asthma
  • +2 more
  • Experimental drug 9MW1911
  • Placebo
  • Beijing, Beijing, China
    Peking Union Hospital
Apr 5, 2023

OSA, Covid19, Residual Symptoms of COVID 19 Trial in College Station (Exercise (Resistance Training)

Recruiting
  • OSA
  • +3 more
  • Exercise (Resistance Training
  • College Station, Texas
    Texas A&M University
May 24, 2022

COPD Trial in Osaka-sayama (balloon-based tongue pressure measurement device)

Completed
  • Chronic Obstructive Pulmonary Disease
  • balloon-based tongue pressure measurement device
  • Ōsaka-sayama, Osaka, Japan
    Kindai University Faculty of Medicine
Feb 17, 2021

COPD, COPD Trial in Wellington (Placebo, TD-4208 700 µg, TD-4208 350 µg)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease, COPD
  • Placebo
  • +3 more
  • Wellington, New Zealand
    P3 Research
Feb 22, 2022

A Six Minute Walking Test Based Index asOutcome Predictor in

Recruiting
  • COPD
  • +3 more
  • evaluation group
  • Tradate, VA, Italy
    Maugeri Foundation
Feb 2, 2021

COPD, COPD, Low Peak Inspiratory Flow Rate (PIFR) Trial in Rock Hill (Revefenacin, Spiriva Handihaler®, Placebo for Revefenacin)

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease, COPD
  • Low Peak Inspiratory Flow Rate (PIFR)
  • Rock Hill, South Carolina
    Clinical Research of Rock Hill
Feb 22, 2022

Asthma, COPD, Interstitial Lung Disease Trial in Kansas City (Hyperpolarized Xe129)

Recruiting
  • Asthma
  • +6 more
  • Hyperpolarized Xe129
  • Kansas City, Kansas
    University of Kansas Medical Center
Nov 12, 2022

Asthma, COPD Trial (SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F ))

Completed
Has Results
  • Asthma
  • COPD
  • SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F )
  • (no location specified)
Feb 7, 2022

COPD Trial in Wellington (TD-4208, Placebo)

Completed
Has Results
  • COPD
  • Wellington, New Zealand
    P3 Research Ltd
Feb 22, 2022

Biological Characteristic Characteristics of Heart and Lung

Completed
  • Chronic Obstructive Pulmonary Disease
    • Hangzhou, Zhejiang, China
      the Third Affiliated Hospital of Zhejiang Chinese Medical Univer
    Jan 10, 2023

    COPD (COPD) Trial in Portland (TD-4208, Placebo)

    Completed
    Has Results
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Portland, Oregon
      Allergy Associates Research Center (AARC)
    Feb 22, 2022